Breast cancer trials 'failing to save younger patients'

A lack of clinical trials aimed at younger breast cancer patients could be partly to blame for longer-term survival problems, experts believe.

The study, funded by Cancer Research UK and the Wessex Cancer Trust, analysed nearly 3,000 women under 40 in the UK with diagnosed breast cancer. It found a rapid rise in relapse after five years in younger patients with a certain type of the cancer. This contrasts with what normally happens with the disease.

The data, published in the Journal of the National Cancer Institute, showed that survival five years after diagnosis was 85%. By the eight-year mark it was 68%.Breast cancer is mostly diagnosed in post-menopausal women, although those with a diagnosis under 40 represent fewer than 5% of all breast cancers treated in the UK.

Editor's Comment
Closure as pain lingers

March 28 will go down as a day that Batswana will never forget because of the accident that occurred near Mmamatlakala in Limpopo, South Africa. The tragedy affected not only the grieving families but the nation at large. Batswana throughout the process stood behind the grieving families and the governments of Botswana and South Africa need much more than a pat on the back.Last Saturday was a day when family members said their last goodbyes to...

Have a Story? Send Us a tip
arrow up